BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 10652580)

  • 21. Expression of Kir 4.1 in human astrocytic tumors: correlation with pathologic grade.
    Tan G; Sun SQ; Yuan DL
    Biochem Biophys Res Commun; 2008 Mar; 367(4):743-7. PubMed ID: 18191638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
    Evin G; Zhu A; Holsinger RM; Masters CL; Li QX
    J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic differences between primary and recurrent human brain tumors: a 1H NMR spectroscopic investigation.
    Lehnhardt FG; Bock C; Röhn G; Ernestus RI; Hoehn M
    NMR Biomed; 2005 Oct; 18(6):371-82. PubMed ID: 15959923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intermediate filament protein synemin is present in human reactive and malignant astrocytes and associates with ruffled membranes in astrocytoma cells.
    Jing R; Pizzolato G; Robson RM; Gabbiani G; Skalli O
    Glia; 2005 Apr; 50(2):107-20. PubMed ID: 15657940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minichromosome maintenance protein 3 elicits a cancer-restricted immune response in patients with brain malignancies and is a strong independent predictor of survival in patients with anaplastic astrocytoma.
    Söling A; Sackewitz M; Volkmar M; Schaarschmidt D; Jacob R; Holzhausen HJ; Rainov NG
    Clin Cancer Res; 2005 Jan; 11(1):249-58. PubMed ID: 15671553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein expression of BACE1, BACE2 and APP in Down syndrome brains.
    Cheon MS; Dierssen M; Kim SH; Lubec G
    Amino Acids; 2008 Aug; 35(2):339-43. PubMed ID: 18163181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of heterozygosity on chromosome 10q associated with malignancy and prognosis in astrocytic tumors, and discovery of novel loss regions.
    Daido S; Takao S; Tamiya T; Ono Y; Terada K; Ito S; Ouchida M; Date I; Ohmoto T; Shimizu K
    Oncol Rep; 2004 Oct; 12(4):789-95. PubMed ID: 15375501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo beta-secretase 1 inhibition leads to brain Abeta lowering and increased alpha-secretase processing of amyloid precursor protein without effect on neuregulin-1.
    Sankaranarayanan S; Price EA; Wu G; Crouthamel MC; Shi XP; Tugusheva K; Tyler KX; Kahana J; Ellis J; Jin L; Steele T; Stachel S; Coburn C; Simon AJ
    J Pharmacol Exp Ther; 2008 Mar; 324(3):957-69. PubMed ID: 18156464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced expression of PDCD5 is associated with high-grade astrocytic gliomas.
    Li H; Wang Q; Gao F; Zhu F; Wang X; Zhou C; Liu C; Chen Y; Ma C; Sun W; Zhang L
    Oncol Rep; 2008 Sep; 20(3):573-9. PubMed ID: 18695908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of the expression of nuclear factor-kappa B, tumor necrosis factor receptor type 1 (TNFR 1) and c-Myc with the clinical course in the treatment of malignant astrocytomas with recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2).
    Yamamoto M; Fukushima T; Hayashi S; Ikeda K; Tsugu H; Kimura H; Soma G; Tomonaga M
    Anticancer Res; 2000; 20(1C):611-8. PubMed ID: 10769704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction of iron-regulated amyloid precursor protein and beta-amyloid peptide by (-)-epigallocatechin-3-gallate in cell cultures: implications for iron chelation in Alzheimer's disease.
    Reznichenko L; Amit T; Zheng H; Avramovich-Tirosh Y; Youdim MB; Weinreb O; Mandel S
    J Neurochem; 2006 Apr; 97(2):527-36. PubMed ID: 16539659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of oxidative stress on amyloid precursor protein processing in cells engaged in beta-amyloidosis is related to apolipoprotein E genotype.
    Mazur-Kolecka B; Kowal D; Sukontasup T; Dickson D; Frackowiak J
    Acta Neuropathol; 2004 Oct; 108(4):287-94. PubMed ID: 15221339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
    Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
    Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteasome-mediated degradation of the C-terminus of the Alzheimer's disease beta-amyloid protein precursor: effect of C-terminal truncation on production of beta-amyloid protein.
    Nunan J; Williamson NA; Hill AF; Sernee MF; Masters CL; Small DH
    J Neurosci Res; 2003 Nov; 74(3):378-85. PubMed ID: 14598314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression and distribution of id helix-loop-helix proteins in human astrocytic tumors.
    Vandeputte DA; Troost D; Leenstra S; Ijlst-Keizers H; Ramkema M; Bosch DA; Baas F; Das NK; Aronica E
    Glia; 2002 Jun; 38(4):329-38. PubMed ID: 12007145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and activity of l-isoaspartyl methyltransferase decrease in stage progression of human astrocytic tumors.
    Lapointe M; Lanthier J; Moumdjian R; Régina A; Desrosiers RR
    Brain Res Mol Brain Res; 2005 Apr; 135(1-2):93-103. PubMed ID: 15857672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promoter hypermethylation of multiple genes in astrocytic gliomas.
    Gonzalez-Gomez P; Bello MJ; Arjona D; Lomas J; Alonso ME; De Campos JM; Vaquero J; Isla A; Gutierrez M; Rey JA
    Int J Oncol; 2003 Mar; 22(3):601-8. PubMed ID: 12579314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated HLA-E levels in human glioblastomas but not in grade I to III astrocytomas correlate with infiltrating CD8+ cells.
    Mittelbronn M; Simon P; Löffler C; Capper D; Bunz B; Harter P; Schlaszus H; Schleich A; Tabatabai G; Goeppert B; Meyermann R; Weller M; Wischhusen J
    J Neuroimmunol; 2007 Sep; 189(1-2):50-8. PubMed ID: 17675252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel alpha-secretase cleavage of Alzheimer's amyloid beta precursor protein in the endoplasmic reticulum of COS7 cells.
    Shin RW; Saido TC; Maeda M; Kitamoto T
    Neurosci Lett; 2005 Mar; 376(1):14-9. PubMed ID: 15694266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo.
    Hussain I; Hawkins J; Harrison D; Hille C; Wayne G; Cutler L; Buck T; Walter D; Demont E; Howes C; Naylor A; Jeffrey P; Gonzalez MI; Dingwall C; Michel A; Redshaw S; Davis JB
    J Neurochem; 2007 Feb; 100(3):802-9. PubMed ID: 17156133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.